Cargando…

FKBP3 mediates oxaliplatin resistance in colorectal cancer cells by regulating HDAC2 expression

Colorectal cancer (CRC), a commonly occurring malignant tumor in the gastrointestinal tract, is the third leading cause of cancer-related deaths worldwide. FK506-binding proteins (FKBPs) comprise an immunophilin family that are involved in the carcinogenesis, progression and chemoresistance of cance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tong, Jiafeng, Shen, Ying, Chen, Xi, Wang, Renjie, Hu, Ye, Zhang, Xu, Zhang, Zhenghua, Han, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718095/ https://www.ncbi.nlm.nih.gov/pubmed/31524278 http://dx.doi.org/10.3892/or.2019.7259

Ejemplares similares

Expression and localization of the immunophilin FKBP51 in colorectal carcinomas and primary metastases, and alterations following oxaliplatin-based chemotherapy
por: Rotoli, Deborah, et al.
Publicado: (2016)

Subcellular Expression Patterns of FKBP Prolyl Isomerase 10 (FKBP10) in Colorectal Cancer and Its Clinical Significance
por: Fu, Yating, et al.
Publicado: (2023)

Role of AMPK in Regulation of Oxaliplatin-Resistant Human Colorectal Cancer
por: Park, Sun Young, et al.
Publicado: (2022)

Ursolic acid enhances the therapeutic effects of oxaliplatin in colorectal cancer by inhibition of drug resistance
por: Zhang, Ye, et al.
Publicado: (2017)

Apigenin inhibits epithelial-mesenchymal transition of human colon cancer cells through NF-κB/Snail signaling pathway
por: Tong, Jiafeng, et al.
Publicado: (2019)

Inhibition of CDK1 Overcomes Oxaliplatin Resistance by Regulating ACSL4‐mediated Ferroptosis in Colorectal Cancer
por: Zeng, Kaixuan, et al.
Publicado: (2023)

FKBP3 Promotes Proliferation of Non-Small Cell Lung Cancer Cells through Regulating Sp1/HDAC2/p27
por: Zhu, Wenzhuo, et al.
Publicado: (2017)

Checkpoint regulator B7x is epigenetically regulated by HDAC3 and mediates resistance to HDAC inhibitors by reprogramming the tumor immune environment in colorectal cancer
por: Li, Yuxin, et al.
Publicado: (2020)

Cyr61 mediates oxaliplatin resistance in colorectal cancer cells by regulating Bcl-xL expression
por: Song, Yanfang, et al.
Publicado: (2021)

Targeting HDAC2-Mediated Immune Regulation to Overcome Therapeutic Resistance in Mutant Colorectal Cancer
por: Conte, Mariarosaria, et al.
Publicado: (2023)

FKBP52 and FKBP51 differentially regulate the stability of estrogen receptor in breast cancer
por: Habara, Makoto, et al.
Publicado: (2022)

Mechanism and Molecular Network of RBM8A-Mediated Regulation of Oxaliplatin Resistance in Hepatocellular Carcinoma
por: Liang, Rong, et al.
Publicado: (2021)

Inhibition of indoleamine 2,3-dioxygenase 1 synergizes with oxaliplatin for efficient colorectal cancer therapy
por: Miao, Xiaofei, et al.
Publicado: (2021)

FKBP51 and FKBP52 regulate androgen receptor dimerization and proliferation in prostate cancer cells
por: Maeda, Keisuke, et al.
Publicado: (2021)

CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancer
por: Hsieh, Chi-Che, et al.
Publicado: (2022)

Screening of molecular targets and construction of a ceRNA network for oxaliplatin resistance in colorectal cancer
por: Wei, Wu, et al.
Publicado: (2019)

Gemcitabine: An Alternative Treatment for Oxaliplatin-Resistant Colorectal Cancer
por: Chocry, Mathieu, et al.
Publicado: (2022)

JUNB mediates oxaliplatin resistance via the MAPK signaling pathway in gastric cancer by chromatin accessibility and transcriptomic analysis: JUNB mediates oxaliplatin resistance in gastric cancer
por: Li, Suyao, et al.
Publicado: (2023)

The Association of CXC Receptor 4 Mediated Signaling Pathway with Oxaliplatin-Resistant Human Colorectal Cancer Cells
por: Huang, Wen-Shih, et al.
Publicado: (2016)

Gambogic acid reverses oxaliplatin resistance in colorectal cancer by increasing intracellular platinum levels
por: Wang, Qiang, et al.
Publicado: (2018)

TRIM25 regulates oxaliplatin resistance in colorectal cancer by promoting EZH2 stability
por: Zhou, Sha, et al.
Publicado: (2021)

Scutellarin resensitizes oxaliplatin-resistant colorectal cancer cells to oxaliplatin treatment through inhibition of PKM2
por: Sun, Wei, et al.
Publicado: (2021)

Modulating FKBP5/FKBP51 and autophagy lowers HTT (huntingtin) levels
por: Bailus, Barbara J., et al.
Publicado: (2021)

Synergistic effect of sodium butyrate and oxaliplatin on colorectal cancer
por: Shuwen, Han, et al.
Publicado: (2022)

WBSCR22 confers oxaliplatin resistance in human colorectal cancer
por: Yan, Dongmei, et al.
Publicado: (2017)

Differential Effects of Fkbp4 and Fkbp5 on Regulation of the Proopiomelanocortin Gene in Murine AtT-20 Corticotroph Cells
por: Kageyama, Kazunori, et al.
Publicado: (2021)

FKBP25 Regulates Meiotic Apparatus During Mouse Oocyte Maturation
por: Wang, Danni, et al.
Publicado: (2021)

FKBP51 and FKBP12.6—Novel and tight interactors of Glomulin
por: Hähle, Andreas, et al.
Publicado: (2019)

Emerging roles of non-coding RNAs in colorectal cancer oxaliplatin resistance and liquid biopsy potential
por: Luo, Zheng-Dong, et al.
Publicado: (2023)

CAMTA1–PPP3CA–NFATc4 multi-protein complex mediates the resistance of colorectal cancer to oxaliplatin
por: Pan, Ruijun, et al.
Publicado: (2022)

KLF5 inhibition overcomes oxaliplatin resistance in patient-derived colorectal cancer organoids by restoring apoptotic response
por: Shen, Xiaohui, et al.
Publicado: (2022)

Knockdown of PKM2 and GLS1 expression can significantly reverse oxaliplatin-resistance in colorectal cancer cells
por: Lu, Wei-Qun, et al.
Publicado: (2017)

Biological Actions of the Hsp90-binding Immunophilins FKBP51 and FKBP52
por: Zgajnar, Nadia R., et al.
Publicado: (2019)

HNF1A regulates oxaliplatin resistance in pancreatic cancer by targeting 53BP1
por: Xia, Renpeng, et al.
Publicado: (2023)

The synergistic effects of oxaliplatin and piperlongumine on colorectal cancer are mediated by oxidative stress
por: Chen, WeiQian, et al.
Publicado: (2019)

FOXC2 Promotes Oxaliplatin Resistance by Inducing Epithelial-Mesenchymal Transition via MAPK/ERK Signaling in Colorectal Cancer
por: Chen, Yihong, et al.
Publicado: (2020)

The Effect of Compound Sophora on Fluorouracil and Oxaliplatin Resistance in Colorectal Cancer Cells
por: Yin, WeiHua, et al.
Publicado: (2019)

Effective Delivery of siRNA-Loaded Nanoparticles for Overcoming Oxaliplatin Resistance in Colorectal Cancer
por: Zhou, Yue, et al.
Publicado: (2022)

Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer
por: Liu, Tong, et al.
Publicado: (2019)

Regulation of CLC-1 chloride channel biosynthesis by FKBP8 and Hsp90β
por: Peng, Yi-Jheng, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_j2i1els72kq5f7et04sblmp218